This article is more than 5 years old. Information may no longer be current.

CIBA recalls Aquify eye drops over sterility issue

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

CIBA Vision initiated a recall last month on one lot of its Aquify eye drops, citing a lack of assurance of sterility at the time of manufacture, according to information from the Food and Drug Administration.

The company is recalling lot No. 52246, which was distributed in the United States, Canada, Germany, Belgium, Luxembourg and the United Kingdom, according to the company.

A total of 29,592 cases of the product were affected; there are 24 units per case. The recall is ongoing, according to the FDA.